Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference

被引:74
作者
Kirchhof, Paulus [1 ,2 ,3 ]
Lip, Gregory Y. H. [3 ]
Van Gelder, Isabelle C. [4 ]
Bax, Jeroen [5 ]
Hylek, Elaine [6 ]
Kaeaeb, Stefan [7 ]
Schotten, Ulrich [8 ]
Wegscheider, Karl [9 ]
Boriani, Giuseppe [10 ]
Ezekowitz, Michael [11 ]
Diener, Hans [12 ]
Heidbuchel, Hein [13 ]
Lane, Deirdre [3 ]
Mont, Luis [14 ]
Willems, Stephan [9 ]
Dorian, Paul [15 ]
Vardas, Panos [16 ]
Breithardt, Guenter [1 ,2 ]
Camm, A. John [17 ]
机构
[1] Hosp Univ Munster, Munster, Germany
[2] AFNET, Munster, Germany
[3] Univ Birmingham, Birmingham B18 7QH, W Midlands, England
[4] Univ Groningen, NL-9700 AB Groningen, Netherlands
[5] Leiden Univ, NL-2300 RA Leiden, Netherlands
[6] Boston Univ, Sch Med, Boston, MA 02118 USA
[7] Univ Munich, D-80539 Munich, Germany
[8] Maastricht Univ, Maastricht, Netherlands
[9] Univ Hamburg, Hamburg, Germany
[10] Univ Bologna, I-40126 Bologna, Italy
[11] Jefferson Med Coll, Wynnewood, PA USA
[12] Univ Essen Gesamthsch, Essen, Germany
[13] Univ Hosp Gasthuisberg, Louvain, Belgium
[14] Univ Barcelona, E-08007 Barcelona, Spain
[15] Univ Toronto, Toronto, ON, Canada
[16] Univ Hosp Herakl, Iraklion, Greece
[17] St Georges Univ, London, England
关键词
Acquired coagulation disorders; vitamin K-dependent factors; stroke; /; prevention; thrombin; atrial fibrillation; CHRONIC HEART-FAILURE; RESEARCH PERSPECTIVES; OUTCOME PARAMETERS; WARFARIN THERAPY; BLOOD-PRESSURE; TASK-FORCE; STROKE; MANAGEMENT; HEMORRHAGE; PREVENTION;
D O I
10.1160/TH11-07-0517
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.
引用
收藏
页码:1012 / 1019
页数:8
相关论文
共 46 条
  • [1] INDEPENDENT RISK-FACTORS FOR ATRIAL-FIBRILLATION IN A POPULATION-BASED COHORT - THE FRAMINGHAM HEART-STUDY
    BENJAMIN, EJ
    LEVY, D
    VAZIRI, SM
    DAGOSTINO, RB
    BELANGER, AJ
    WOLF, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (11): : 840 - 844
  • [2] Prevention of Atrial Fibrillation Report From a National Heart, Lung, and Blood Institute Workshop
    Benjamin, Emelia J.
    Chen, Peng-Sheng
    Bild, Diane E.
    Mascette, Alice M.
    Albert, Christine M.
    Alonso, Alvaro
    Calkins, Hugh
    Connolly, Stuart J.
    Curtis, Anne B.
    Darbar, Dawood
    Ellinor, Patrick T.
    Go, Alan S.
    Goldschlager, Nora F.
    Heckbert, Susan R.
    Jalife, Jose
    Kerr, Charles R.
    Levy, Daniel
    Lloyd-Jones, Donald M.
    Massie, Barry M.
    Nattel, Stanley
    Olgin, Jeffrey E.
    Packer, Douglas L.
    Po, Sunny S.
    Tsang, Teresa S. M.
    Van Wagoner, David R.
    Waldo, Albert L.
    Wyse, D. George
    [J]. CIRCULATION, 2009, 119 (04) : 606 - 618
  • [3] Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]
  • [4] Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers
    Capucci, A
    Santini, M
    Padeletti, L
    Gulizia, M
    Botto, G
    Boriani, G
    Ricci, R
    Favale, S
    Zolezzi, F
    Di Belardino, N
    Molon, G
    Drago, F
    Villani, GQ
    Mazzini, E
    Vimercati, M
    Grammatico, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (10) : 1913 - 1920
  • [5] A Clinical Risk Score for Atrial Fibrillation in a Biracial Prospective Cohort (from the Atherosclerosis Risk In Communities [ARIC] Study)
    Chamberlain, Alanna M.
    Agarwal, Sunil K.
    Folsom, Aaron R.
    Soliman, Elsayed Z.
    Chambless, Lloyd E.
    Crow, Richard
    Ambrose, Marietta
    Alonso, Alvaro
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (01) : 85 - 91
  • [6] Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women
    Conen, David
    Tedrow, Usha B.
    Koplan, Bruce A.
    Glynn, Robert J.
    Buring, Julie E.
    Albert, Christine M.
    [J]. CIRCULATION, 2009, 119 (16) : 2146 - 2152
  • [7] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Yusuf, Salim
    Eikelboom, John
    Oldgren, Jonas
    Parekh, Amit
    Pogue, Janice
    Reilly, Paul A.
    Themeles, Ellison
    Varrone, Jeanne
    Wang, Susan
    Alings, Marco
    Xavier, Denis
    Zhu, Jun
    Diaz, Rafael
    Lewis, Basil S.
    Darius, Harald
    Diener, Hans-Christoph
    Joyner, Campbell D.
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) : 1139 - 1151
  • [8] Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter
    Connolly, Stuart J.
    Crijns, Harry J. G. M.
    Torp-Pedersen, Christian
    van Eickels, Martin
    Gaudin, Christophe
    Page, Richard L.
    Hohnloser, Stefan H.
    [J]. CIRCULATION, 2009, 120 (13) : 1174 - 1180
  • [9] Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode
    Cosio, Francisco G.
    Aliot, Etienne
    Botto, Giovanni Luca
    Heidbuchel, Hein
    Geller, Christoph Johan
    Kirchhof, Paulus
    De Haro, Jean-Claude
    Frank, Robert
    Villacastin, Julian Perez
    Vijgen, Johan
    Crijns, Harry
    [J]. EUROPACE, 2008, 10 (01): : 21 - 27
  • [10] Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study
    Devereaux, PJ
    Anderson, DR
    Gardner, MJ
    Putnam, W
    Flowerdew, GJ
    Brownell, BF
    Nagpal, S
    Cox, JL
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7323): : 1218 - 1221